GERMAINE ESCAMES ROSA-rekin lankidetzan egindako argitalpenak (11)

2011

  1. Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy

    Clinical Biochemistry, Vol. 44, Núm. 10-11, pp. 853-858

2010

  1. Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy

    Journal of Pineal Research, Vol. 48, Núm. 3, pp. 282-289

2002

  1. Evaluation of plasma levels of melatonin after midazolam or sodium thiopental anesthesia in children

    Journal of Pineal Research, Vol. 32, Núm. 4, pp. 253-256

2001

  1. Characterization of nocturnal ultradian rhythms of melatonin in children with growth hormone-dependent and independent growth delay

    Journal of Clinical Endocrinology and Metabolism, Vol. 86, Núm. 3, pp. 1181-1187

  2. Effect of propranolol plus exercise on melatonin and growth hormone levels in children with growth delay

    Journal of Pineal Research, Vol. 30, Núm. 2, pp. 75-81

  3. Melatonin and β-endorphin changes in children sensitized to olive and grass pollen after treatment with specific immunotherapy

    International Archives of Allergy and Immunology, Vol. 126, Núm. 1, pp. 91-96

2000

  1. Effect of clonidine on plasma ACTH, cortisol and melatonin in children

    Journal of Pineal Research, Vol. 29, Núm. 1, pp. 48-53

1998

  1. Melatonin's role as an anticonvulsant and neuronal protector: Experimental and clinical evidence

    Journal of Child Neurology, Vol. 13, Núm. 10, pp. 501-509

1997

  1. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates

    Neuroscience Letters, Vol. 230, Núm. 3, pp. 147-150

  2. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation

    FEBS Letters, Vol. 408, Núm. 3, pp. 297-300

1995

  1. Minireview: Cell protective role of melatonin in the brain

    Journal of Pineal Research, Vol. 19, Núm. 2, pp. 57-63